메뉴 건너뛰기
Journal of Clinical Psychiatry
Volumn 68, Issue 9, 2007, Pages 1445-1446
Aripiprazole-induced psychosis: A case report of reexposure by stepwise up-titration [3]
Author keywords

[No Author keywords available]
Indexed keywords

ARIPIPRAZOLE; RISPERIDONE;
EID: 34948826011     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/jcp.v68n0919c     Document Type: Letter
Times cited : (5)
References (13)
  • 1
    • 20144386748 scopus 로고    scopus 로고
    • Aripiprazole in schizophrenia: Consensus guidelines
    • Travis MJ, Burns T, Dursun S, et al. Aripiprazole in schizophrenia: consensus guidelines. Int J Clin Pract 2005;59:485-495
    • (2005) Int J Clin Pract , vol.59 , pp. 485-495
    • Travis, M.J.1    Burns, T.2    Dursun, S.3
  • 2
    • 0037393107 scopus 로고    scopus 로고
    • Switching patients to aripiprazole from other antipsychotic agents: A multicenter randomized study
    • Casey DE, Carson WH, Saha AR, et al. Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study. Psychopharmacology 2003;166:391-399
    • (2003) Psychopharmacology , vol.166 , pp. 391-399
    • Casey, D.E.1    Carson, W.H.2    Saha, A.R.3
  • 3
    • 4344714861 scopus 로고    scopus 로고
    • Aripiprazole: A review of its use in schizophrenia and schizoaffective disorder
    • Swainston Harrison T, Perry CM. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder. Drugs 2004;64:1715-1736
    • (2004) Drugs , vol.64 , pp. 1715-1736
    • Swainston Harrison, T.1    Perry, C.M.2
  • 5
    • 3042699593 scopus 로고    scopus 로고
    • Worsening schizoaffective disorder with aripiprazole [letter]
    • Reeves RR, Mack JE. Worsening schizoaffective disorder with aripiprazole [letter]. Am J Psychiatry 2004;161:1308
    • (2004) Am J Psychiatry , vol.161 , pp. 1308
    • Reeves, R.R.1    Mack, J.E.2
  • 6
    • 27544488756 scopus 로고    scopus 로고
    • Treatment-emergent psychosis wim aripiprazole [letter]
    • Barnas ME, Hussain N, Petrides G. Treatment-emergent psychosis wim aripiprazole [letter]. J Clin Psychiatry 2005;66:1339
    • (2005) J Clin Psychiatry , vol.66 , pp. 1339
    • Barnas, M.E.1    Hussain, N.2    Petrides, G.3
  • 7
    • 1442332132 scopus 로고    scopus 로고
    • Worsened agitation with aripiprazole: Adverse effect of dopamine partial agonism? [letter]
    • DeQuardo JR. Worsened agitation with aripiprazole: adverse effect of dopamine partial agonism? [letter] J Clin Psychiatry 2004;65:132-133
    • (2004) J Clin Psychiatry , vol.65 , pp. 132-133
    • DeQuardo, J.R.1
  • 8
    • 33645242210 scopus 로고    scopus 로고
    • Aripiprazole and suicidality [case report]
    • Holzer L, Eap CB. Aripiprazole and suicidality [case report]. Int Clin Psychopharmacol 2006;21:125-126
    • (2006) Int Clin Psychopharmacol , vol.21 , pp. 125-126
    • Holzer, L.1    Eap, C.B.2
  • 9
    • 0023606101 scopus 로고
    • The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
    • Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276
    • (1987) Schizophr Bull , vol.13 , pp. 261-276
    • Kay, S.R.1    Fiszbein, A.2    Opler, L.A.3
  • 10
    • 24144445638 scopus 로고    scopus 로고
    • Therapeutic monitoring of aripiprazole by HPLC with column-switching and spectrophotometric detection
    • Kirschbaum KM, Müller MJ, Zernig G, et al. Therapeutic monitoring of aripiprazole by HPLC with column-switching and spectrophotometric detection. Clin Chem 2005;51:1718-1721
    • (2005) Clin Chem , vol.51 , pp. 1718-1721
    • Kirschbaum, K.M.1    Müller, M.J.2    Zernig, G.3
  • 11
    • 0031828859 scopus 로고    scopus 로고
    • Serum concentrations and side effects in psychiatric patients during risperidone therapy
    • Olesen OV, Licht RW, Thomsen E, et al. Serum concentrations and side effects in psychiatric patients during risperidone therapy. Ther Drug Monit 1998;20:380-384
    • (1998) Ther Drug Monit , vol.20 , pp. 380-384
    • Olesen, O.V.1    Licht, R.W.2    Thomsen, E.3
  • 12
    • 0033626576 scopus 로고    scopus 로고
    • Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: A clinical PET study
    • Silvestri S, Seeman MV, Negrete JC, et al. Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharmacology (Berl) 2000;152:174-180
    • (2000) Psychopharmacology (Berl) , vol.152 , pp. 174-180
    • Silvestri, S.1    Seeman, M.V.2    Negrete, J.C.3
  • 13
    • 0035038086 scopus 로고    scopus 로고
    • Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: Implications for antipsychotic drug treatment
    • Tarazi FI, Zhang K, Baldessarini RJ. Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment. J Pharmacol Exp Ther 2001;297:711-717
    • (2001) J Pharmacol Exp Ther , vol.297 , pp. 711-717
    • Tarazi, F.I.1    Zhang, K.2    Baldessarini, R.J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.